Royalty Pharma plc (RPRX) stock
RPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 8/3060% above fair value
$69.31+0.34 (+0.49%)
Close on Nov 13, 2026Market cap $39.85BP/E 48.8Yield –
Royalty Pharma statistics
84 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 10, 2027 (estimated, before the open)
- Last ex-dividend date
- Nov 13, 2026
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/OCF Ratio
- 13.46
- 12.99
Enterprise valuationIndustry
- EV / Sales
- 19.43
- 2.57
- EV / EBIT
- 34.01
- 19.31
Share statisticsIndustry
- Shares Change (YoY)
- -2.67%
- 10.8%
- Float
- 445M
- 49M
- Shares Held by Insiders
- 22.6%
- 11.7%
- Shares Held by Institutions
- 63.8%
- 56.4%
Short sellingIndustry
- Short Interest
- 13M
- –
- Short Interest Change
- 1.81%
- -0.80%
- Short % of Float
- 2.94%
- 9.01%
- Short % of Shares Outstanding
- 2.27%
- 6.30%
- Days to Cover
- 3.97
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $70.37
- –
- 52-Week Low
- $37.31
- –
- 20-Day Moving Average
- $66.11
- –
- 50-Day Moving Average
- $61.51
- –
- 200-Day Moving Average
- $54.63
- –
- Average True Range (14)
- $1.57
- –
- Price Change (1 Week)
- 2.99%
- -1.15%
- Price Change (1 Month)
- 16.3%
- -4.87%
- Price Change (3 Months)
- 16.6%
- -21.0%
- Price Change (6 Months)
- 31.1%
- -20.6%
- Price Change (YTD)
- 79.4%
- -23.6%
- Price Change (1 Year)
- 75.1%
- -22.4%
- Price Change (3 Years)
- 151.9%
- -29.5%
- Price Change (5 Years)
- 65.3%
- -77.9%
- Average Volume (10 Days)
- 4M
- –
- Average Volume (20 Days)
- 3M
- –
- Average Volume (90 Days)
- 3M
- –
- Relative Volume
- 0.96
- 0.70
- Relative Strength Index (14)
- 72.2
- 43.4
- Volatility (1 Year)
- 22.1%
- 80.1%
- Beta (5 Years)
- 0.41
- 1.07
MarginsIndustry
- Pretax Margin
- 44.8%
- -11.6%
- EBITDA Margin
- 57.1%
- -27.7%
Returns on capitalIndustry
- Return on Assets (ROA)
- 3.47%
- -40.6%
- Return on Capital Employed (ROCE)
- 8.18%
- -37.9%
Financial positionIndustry
- Current Ratio
- 1.29
- 3.30
- Quick Ratio
- 0.46
- 2.39
- Debt / EBITDA
- 5.74
- 3.15
- Net Debt / EBITDA
- 5.38
- 1.97
- Interest Coverage
- 4.02
- -6.35
GrowthIndustry
- Revenue Growth (YoY)
- 11.4%
- 6.82%
- Net Income Growth (YoY)
- -12.0%
- -14.4%
- EPS Growth (YoY)
- -12.9%
- -12.3%
- Revenue Growth (3Y CAGR)
- 2.06%
- 2.25%
- Revenue Growth (5Y CAGR)
- 2.30%
- 6.41%
- EPS Growth (3Y CAGR)
- 161.1%
- 1.30%
- EPS Growth (5Y CAGR)
- 6.16%
- 3.78%
EfficiencyIndustry
- Asset Turnover
- 0.13
- 0.40
- Revenue Per Employee
- $26.17M
- $429.29K
- Profits Per Employee
- $6.72M
- -$689.41K
- Employee Count
- 100
- 74
- WACC
- 7.16%
- 10.2%
Income statement (TTM)Industry
- Pretax Income
- $1.17B
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- -$8.04B
- $17.76M
- Net Cash Per Share
- -$13.99
- $0.80
- Working Capital
- $346.56M
- $79.99M
Cash flow (TTM)Industry
Dividends and yieldsIndustry
- Earnings Yield
- 1.69%
- -21.8%
- Buyback Yield
- 0.66%
- -0.76%
- Shareholder Yield
- 0.66%
- 0.00%
Taxes and interestIndustry
- Interest Expense
- $372.00M
- $2.90M
- Income Tax
- $0
- $73.00K
- Effective Tax Rate
- 0.00%
- 20.9%
Scores and fair valueIndustry
- Altman Z-Score
- 3.06
- 0.23
- Piotroski F-Score
- 5
- 4
- Lynch Fair Value
- $8.75
- –
- Lynch Upside
- -87.4%
- -28.9%
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | RPRX | S&P 500 | Difference | RPRX per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +22.9% | -3.0% | +26.0 pts | ||
| 3 months | +19.2% | -2.8% | +22.0 pts | ||
| Year to date | +82.5% | +11.5% | +71.0 pts | ||
| 1 year | +78.4% | +13.5% | +65.0 pts | ||
| 3 years | +177.0% | +77.7% | +99.3 pts | +40.4% | +21.1% |
| 5 years | +86.5% | +72.6% | +13.9 pts | +13.3% | +11.5% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
13M RPRX shares were sold short on Oct 30, 2026, up 1.8% from the previous report, or 2.94% of the shares available to trade. At recent volumes it would take 4.0 days to buy them back. Over the last 20 sessions, 46.4% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 13,075,722 | +1.8% | 3,296,900 | 4.0 |
| Oct 15, 2026 | 12,843,101 | -0.3% | 3,001,466 | 4.3 |
| Sep 30, 2026 | 12,885,147 | +10.6% | 2,901,553 | 4.4 |
| Sep 15, 2026 | 11,647,565 | -2.2% | 3,588,237 | 3.3 |
| Aug 31, 2026 | 11,903,716 | +2.6% | 2,359,488 | 5.0 |
| Aug 14, 2026 | 11,606,728 | +8.8% | 3,076,318 | 3.8 |
| Jul 31, 2026 | 10,667,818 | -12.1% | 2,620,765 | 4.1 |
| Jul 15, 2026 | 12,134,646 | -2.5% | 2,734,023 | 4.4 |
| Jun 30, 2026 | 12,443,449 | +11.8% | 4,175,279 | 3.0 |
| Jun 15, 2026 | 11,133,208 | -3.9% | 3,667,098 | 3.0 |
| May 29, 2026 | 11,588,307 | -8.6% | 4,694,064 | 2.5 |
| May 15, 2026 | 12,683,834 | -8.2% | 3,822,354 | 3.3 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?